A next-generation sequencing (NGS)–based technique was used for MSI analysis in 4,553 patients with various tumor types. Upon request, somatic BRAF gene analysis was conducted. In addition, hereditary ...
To assess implementation of a next-generation sequencing (NGS) assay to detect microsatellite instability (MSI) as a screen for Lynch syndrome (LS) in endometrial cancer (EC), while determining and ...
The College of American Pathologists (CAP) has developed a guideline on testing for mismatch repair (MMR) and microsatellite instability (MSI) for patients considered for immune checkpoint inhibitor ...
MADISON, Wis.--(BUSINESS WIRE)--Promega Corporation today announced it plans to develop and commercialize a microsatellite instability (MSI) companion diagnostic (CDx) IVD kit with GSK to identify ...
Merck & Co. has tapped the artificial intelligence developer Owkin to help assemble a new slate of digital diagnostics for cancer testing. The collaboration will expand upon Owkin’s machine ...
Promega has scored an FDA green light for its microsatellite instability testing technology as a companion diagnostic for Merck and Eisai’s Keytruda-Lenvima combination for patients with advanced ...
One in every three people is expected to have cancer in their lifetime, making it a major health concern for mankind. A crucial indicator of the outcome of cancer is its tumor microsatellite ...
Mayo Clinic has developed a screening procedure that could boost testing for Lynch syndrome, a genetic disorder linked to some types of colorectal cancer, according to a report from EndoNurse.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results